Aim: The aim of this study is to develop two simple, rapid, accurate, economical validated spectrophotometric for simultaneous estimation of bromhexine and cephalexin in bulk and dosage form. Materials and Methods: The Method-I is first derivative spectrophotometric and Method-II is the simultaneous equation method. Both the methods were employed for the analysis of drugs bromhexine and cephalexin using methanol and ammonium hydrogen phosphate (pH 7.7) in the ratio of 60:40 as a diluent. Results and Discussions: Both the methods are used for the simultaneous determination of bromhexine and cephalexin at 2155 nm and 266.5 nm, respectively, over the concentration range of 0.2-1.2 μg/ml and 12.5-75 μg/ml with the correlation coefficient (r 2 ) 0.9996 and 0.9994. Conclusions: The recovery studies confirmed the accuracy of proposed method and low-value standard deviation confirmed precession of method. The method is validated as per the International Council for Harmonization guidelines.
INTRODUCTION
B romhexine [ Figure 1 ], 2, 4-dibromo-6-{[cyclohexyl (methyl) amino] methyl} aniline is widely used in medicine as a mucolytic drug. It works through decreasing the amount of respiratory tract fluid and reduces its viscosity by activating enzymes that hydrolyze mucopolysaccharides. [1, 2] The drug is official in the Indian Pharmacopoeia (IP) [3] and British Pharmacopoeia (BP). [4] Several methods have been reported spectrophotometry, [5] [6] [7] high-performance liquid chromatography (HPLC). [8] [9] [10] [11] [12] [13] [14] Cephalexin [ Figure 1 ] is chemically {(6R, 7R)-7-[(R)-2-amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo [4.2.0] oct-2-ene-2-carboxylic acid monohydrate} [15] which is a first-generation cephalosporins for oral administration which is bactericidal and mainly used in the treatment of various bacterial infections caused by Grampositive and Gram-negative microorganisms. [16] Cephalexin is official in IP, [17] United States Pharmacopoeia, [18] and BP. [19] Literature survey revealed that spectrophotometric, [20] [21] [22] HPLC, [23] [24] [25] [26] [27] and one HPLC method [28] have been reported for this combination drug.
MATERIALS AND METHODS

Chemicals and materials
Pure standard drugs such as bromhexine and cephalexin were obtained as gift samples from reputed pharmaceutical company. Methanol and ammonium hydrogen phosphate (Merck, Mumbai, India) were of analytical grade. Formulations of Cep-Bro tablet pharmaceutical dosage form of cephalexin and bromhexine containing labeled amount of cephalexin-250 mg and bromhexine-4mg were procured from local market.
Instrumentation
Teccomp ultraviolet (UV)-2301 double-beam UV-visible spectrophotometer was used to carry out spectral analysis, and the data were recorded by Hitachi software. Standard and sample drugs were weighed using Denver electronic analytical balance (SI-234).
Preparation of standard and sample solution 10mg of each standard drug was accurately weighed and dissolved in 5 ml diluent, methanol, and ammonium hydrogen phosphate (pH 7.7) in the ratio of 60:40 v/v, then transferred to a 10ml volumetric flask and sonicated for 5 min, and finally, volume was made up to the mark with the same solvent to make 1000 µg/ml stock solution. 100 µg/ ml solution of each drug was prepared by diluting the above stock solution to 10ml and was used for preparing solutions of required concentrations. Combined solution of 1 ml of each drug solution was used for the simultaneous estimation of bromhexine and cephalexin.
Preparation of sample solution
For the analysis of tablet formulation, 10 tablets (Cep-Bro; cephalexin-250mg and bromhexine-4 mg) were weighed and powdered finely. From the tablet powder, an amount powder equivalent to 10mg of cephalexin standard was weighed accurately, dissolved in 10ml solvent, and the content was sonicated for 10-15 min to dissolve the drug completely in the solvent. Then, it was filtered and made up to 10 ml with same diluents methanol and ammonium hydrogen phosphate (pH 7.7) in the ratio of 60:40 v/v to prepare 1000 µg/ml cephalexin stock solution. From this stock solution, 50 µg/ml cephalexin sample solution was prepared. As per the label claim of the two drugs, a bromhexine concentration of 0.8 µg/ml was obtained. The resultant solution was used for the simultaneous estimation of cephalexin and bromhexine in combined dosage form.
Method-I: First-order derivative spectrophotometry
In this method, standard stock solutions of bromhexine and cephalexin were prepared and scanned in the spectrum mode from 200 nm to 400 nm. The absorption spectrum obtained was derivatized from first to fourth order. A first-order derivative spectrum was selected for the analysis of drugs. From the spectra of drugs, the maximum absorbance was observed at 266.5 nm for bromhexine and 215.5 nm for cephalexin and zero cross = 279 nm, and these two wavelengths can be applied for the determination of bromhexine and cephalexin without any interference from the other drug in their pure and combined dosage forms [ Figure 2 ]. The proposed method was validated as per the International Council for Harmonization (ICH) guideline. [29] 
Method-II: Simultaneous equation method
Working standard solutions of bromhexine and cephalexin were prepared separately from standard stock solution. These solutions were scanned in the spectrum mode from 400.0 nm to 200.0 nm. The maximum absorbance of bromhexine and cephalexin was observed at 266.5 nm and 215.5 nm, respectively [ Figure 3 ]. The linearity of bromhexine and cephalexin was found to be in the concentration ranges of 0.2-1.2 μg/ml and 12.5-75 μg/ml, respectively, at their respective maxima. Two simultaneous equations were formed using these absorptivity coefficient values. 
RESULTS AND DISCUSSIONS
First-order derivative spectrophotometric method (Method-I)
The proposed method was based on first-order derivative spectrophotometry for the simultaneous estimation of bromhexine and cephalexin in UV region using methanol and ammonium hydrogen phosphate (pH 7.7) in the ratio of 60:40 v/v. Beer's law obeyed in the concentration range of 0.2-1.2 μg/ml and 12.5-75 μg/ml for bromhexine and cephalexin, respectively. The correlation coefficient (r 2 ) values were found to be 0.999 for both drugs which show that absorbance of both drugs was linear within the mentioned Figure 4 ]. All the validation parameters were found to be within the permitted level and were given in Table 2 . Marketed brand of the tablet was analyzed and the amount of drugs determined by proposed method was found to be 99.125 and 99.142 for bromhexine and cephalexin, respectively [ Table 3 ]. 
Simultaneous equation method (Method-II)
A six-point calibration curves were obtained in a concentration range of 0.2-1.2 µg/ml and 12.5-75µg/ml for bromhexine and cephalexin, respectively. The response of the drugs was found to be linear in the concentration range, and the linear regression equations were y = 0.2553x + 0.0415 with the correlation coefficient r² = 0.9993 for bromhexine and y = 0.0192x + 0.0524 with the correlation coefficient r² = 0.9996 for cephalexin [ Table 4 and Figure 5 ]. All the validation parameters were found to be with in the permitted level and were given in Table 5 . Marketed brand of the tablet was analyzed and the amount of drug determined by proposed methods was found to be 98.064 and 98.263 for bromhexine and cephalexin, respectively [ Table 5 ]. The stability studies indicated that appreciable changes were observed by treating the drug with UV light, thermal stress, oxidation, acidic hydrolysis, and basic hydrolysis; however, no appreciable change was observed with sunlight. The results of stability studies were given in Table 5 . Thus, the methods are useful for the simultaneous determination of bromhexine and cephalexin in bulk and pharmaceutical formulations.
CONCLUSIONS
The proposed methods (I and II), i.e., first-order derivative spectrophotometric and simultaneous equation are found to be very simple and rapid, can be performed using spectrophotometer, and does not require much costly instruments. It also shows good linearity and sensitivity.
Results of the analysis were validated as per the ICH guidelines. Stability testing study including the effect of temperature, oxidation, photolysis, and susceptibility to hydrolysis across a wide range of pH is performed. Thus, the methods are applicable for simple economical estimation of bromhexine and cephalexin in their pharmaceutical dosage forms.
